Skip To Main Content
Ying LEE on Muck Rack

Ying LEE

As seen in: Wiley Online Library, Yahoo News, BMJ Open, MDPI, JAMA (The Journal of the American Medical Association), Nasdaq, Business Standard, The Star (Malaysia), Cell Reports, Perth Now and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Ying

Contact Ying, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Tuning the topological winding number by rolling up graphene

|
By Ying LEE, Yu Zhong, Ion Cosma Fulga
| tu-dresden.de
Nanoscrolls, radial superlattices formed by rolling up a nanomembrane, exhibit distinct electronic and magneto-transport properties compared to their flat counterparts. In this study, we theoretically demonstrate that the conductance can be precisely enhanced N times by rolling up graphene into an N[jls-end-space/]-turn nanoscroll and applying a longitudinal magnetic field.
Open in Who Shared Issue with article?

Ethnic Disparities in Acute Stroke Presentation and Reperfusion Therapy in a Dutch Comprehensive Stroke Center

|
By Ying LEE, Pjotr V. Hurkmans, Henk J. Arwert
| medRxiv
Abstract Objective: To assess ethnic disparities in time to hospital presentation, use of acute reperfusion therapies, and in-hospital treatment times among patients presenting with stroke in a Dutch emergency department. Methods: In this single-centre observational cohort study, we included patients with a first-ever ischemic stroke between September 2020 and September 2021. Patients were categorized by ethnicity (with or without migration background).
Open in Who Shared Issue with article?

Association of glucagon‐like peptide‐1 receptor agonist use with clinical outcomes in patients with rheumatoid arthritis and type 2 diabetes

|
By Yu-Ting Yu, Ying LEE, Yu-Wei Fang
| Wiley Online Library Verified
INTRODUCTION Rheumatoid arthritis is a chronic systemic autoimmune disease characterized by progressive joint destruction and systemic involvement1, 2. Patients with rheumatoid arthritis have a markedly increased risk of developing type 2 diabetes mellitus, driven by chronic inflammation, altered adipokine and cytokine profiles, reduced physical activity, and prolonged glucocorticoid exposure, all of which contribute to insulin resistance and metabolic dysfunction3-5.
Open in Who Shared Issue with article?
See all 41 licensed articles (46 Total)